Anti-ganglioside GD3 Recombinant Antibody (Mitumomab) (CAT#: TAB-764)

Recombinant mouse monoclonal antibody expressed in CHO binding to human ganglioside GD3. Mitumomab is a mouse monoclonal antibody investigated for the treatment of small cell lung carcinoma in combination with BCG vaccination. Mitumomab attacks tumour cells, while the vaccine is thought to activate the immune system.


Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Fc Engineering:
  • Gene Expression
  • Datasheet
  • MSDS
  • COA
Normal Tissue
RNA Expression

Specifications

  • Immunogen
  • The details of the immunogen for this antibody are not available.
  • Host Species
  • Mouse
  • Derivation
  • Mouse
  • Type
  • IgG2b - kappa
  • Species Reactivity
  • Human
  • Applications
  • Suitable for use in ELISA, FC, IP, FuncS, IF, Neut, ICC and most other immunological methods.
  • CAS
  • 216503-58-1
  • Generic Name
  • mitumomab
  • Related Disease
  • Melanoma

Product Property

  • Purity
  • >95.0% as determined by analysis by RP-HPLC.
  • Storage
  • Store the antibody (in aliquots) at -20°C. Avoid repeated freezing and thawing of samples.

Target

  • Alternative Names
  • mitumomab;216503-58-1;BEC-2;ST8SIA1;ST8 alpha-N-acetyl-neuraminide alpha-2, 8-sialyltransferase 1;sialyltransferase 8 (alpha N acetylneuraminate: alpha 2, 8 sialytransferase, GD3 synthase) A , SIAT8, SIAT8A;alpha-N-acetylneuraminide alpha-2, 8-sialyltrans

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Mitumomab"

Afuco™ Anti-ST8SIA1 ADCC Recombinant Antibody (Mitumomab), ADCC Enhanced
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant mouse monoclonal antibody expressed in CHO binding to human ganglioside GD3. Mitumomab is a mouse monoclonal antibody investigated for the treatment of small cell lung carcinoma in combination with BCG vaccination. Mitumomab attacks tumour cells, while the vaccine is thought to activate the immune system.

See other products for "ST8SIA1"

Single-domain Antibody

CAT Product Name Application Type
NAB-2338-VHH Recombinant Anti-Human ST8SIA1 VHH Single Domain Antibody WB, ICC, ChiP, FA, ELISA Llama VHH

Recombinant Antibody

CAT Product Name Application Type
MOB-3542z Mouse Anti-ST8SIA1 Recombinant Antibody (clone 30D11) WB, IP, IF, ELISA Mouse IgG1, λ

Chicken IgY Antibody

CAT Product Name Application Type
BRD-0561MZ Chicken Anti-ST8SIA1 Polyclonal IgY WB Chicken antibody

ADCC Enhanced Antibody

CAT Product Name Application Type
AFC-TAB-764 Afuco™ Anti-ST8SIA1 ADCC Recombinant Antibody (Mitumomab), ADCC Enhanced ELISA, FC, IP, FuncS, IF, Neut ADCC enhanced antibody

Customer Reviews and Q&As

Submit a review or a question
There are currently no Customer reviews or questions for TAB-764. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© 2024 Creative Biolabs.
  • 0
  • 0
Cart

    Go to compare